During the past decade, Presidio Ospedaliero Matera conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Presidio Ospedaliero Matera" #1 collaborator was "Fondazione Italiana Linfomi ONLUS" with 2 trials as a collaborator, "INTERNATIONAL T-CELL NON-HODGKIN'S LYMPHOMA STUDY GROUP" with 1 trials as a collaborator and "The International Non-Hodgkin Lymphoma Prognostic Factor Project" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Presidio Ospedaliero Matera" are "Atrial Fibrillation" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials), "Follicular Lymphoma Grade 3A" (1 trials), "Follicular Lymphoma, Grade 1" (1 trials) and "Follicular Lymphoma, Grade 2" (1 trials). Many other conditions were trialed in "Presidio Ospedaliero Matera" in a lesser frequency.

Most popular intervention types in "Presidio Ospedaliero Matera" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Bendamustine+Rituximab" (1 trials), "Ibritumomab Tiuxetan + Maintenance" (1 trials), "Maintenance weekly x4" (1 trials) and "OFATUMUMAB" (1 trials). Other intervention names were less common.

The vast majority of trials in "Presidio Ospedaliero Matera" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Presidio Ospedaliero Matera". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Presidio Ospedaliero Matera, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Presidio Ospedaliero Matera, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".